Literature DB >> 32942970

Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update.

Jiahua Cui1, Jinping Jia1.   

Abstract

COX-2, a key enzyme that catalyzed the rate-limiting steps in the conversion of arachidonic acid to prostaglandins, played a pivotal role in the inflammatory process. Different from other family members, COX-2 was barely detectable in normal physiological conditions and highly inducible during the acute inflammatory response of human bodies to injuries or infections. Therefore, the therapeutic utilization of selective COX-2 inhibitors has already been considered as an effective approach for the treatment of inflammation with diminished side effects. Currently, both traditional and newer NSAIDs are the commonly prescribed medications that treat inflammatory diseases by targeting COX-2. However, due to the cardiovascular side-effects of the NSAIDs, finding reasonable alternatives for these frequently prescribed medicines are a hot spot in medicinal chemistry research. Naturallyoccurring compounds have been reported to inhibit COX-2, thereby possessing beneficial effects against inflammation and certain cell injury. The review mainly concentrated on recently identified natural products and derivatives as COX-2 inhibitors, the characteristics of their structural core scaffolds, their anti-inflammatory effects, molecular mechanisms for enzymatic inhibition, and related structure-activity relationships. According to the structural features, the natural COX-2 inhibitors were mainly divided into the following categories: natural phenols, flavonoids, stilbenes, terpenoids, quinones, and alkaloids. Apart from the anti-inflammatory activities, a few dietary COX-2 inhibitors from nature origin also exhibited chemopreventive effects by targeting COX-2-mediated carcinogenesis. The utilization of these natural remedies in future cancer prevention was also discussed. In all, the survey on the characterized COX-2 inhibitors from natural sources paves the way for the further development of more potent and selective COX-2 inhibitors in the future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COX-2 inhibitors; anticancer; antiinflammatoryzzm321990agents; flavonoids; natural products; structure-activity relationships; terpenoids

Year:  2021        PMID: 32942970     DOI: 10.2174/0929867327999200917150939

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Effect of Parecoxib Sodium Preemptive Analgesia on the Recovery Period of General Anesthesia in Patients Undergoing Glioma Resection.

Authors:  Lijuan Zhu; Hui Guo; Tao Zheng; Jing Zhu
Journal:  J Oncol       Date:  2022-06-13       Impact factor: 4.501

2.  Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.

Authors:  Jiahua Cui; Jinping Jia
Journal:  Eur J Med Chem       Date:  2021-08-18       Impact factor: 6.514

3.  Formononetin ameliorates IL‑13‑induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathway.

Authors:  Juanjuan Huang; Xianfeng Chen; Aihua Xie
Journal:  Mol Med Rep       Date:  2021-09-30       Impact factor: 3.423

Review 4.  Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease.

Authors:  Meng-Yue Shi; Lian Liu; Fu-Yuan Yang
Journal:  World J Stem Cells       Date:  2022-09-26       Impact factor: 5.247

5.  Immunomodulatory Properties of Polysaccharides from the Coral Pseudopterogorgia americana in Macrophages.

Authors:  Oleg V Chernikov; Hsiao-Wen Chiu; Lan-Hui Li; Maxim S Kokoulin; Valentina I Molchanova; Hsien-Ta Hsu; Chen-Lung Ho; Kuo-Feng Hua
Journal:  Cells       Date:  2021-12-14       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.